Navigation Links
Delcath Systems, Inc. Hosts Symposium on Chemosaturation at the SOBRICE Annual Meeting in Brazil
Date:8/15/2011

harmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metas
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Delcath Systems Announces the Sale of 5,185,000 Shares of Common Stock
2. Delcath Highlights Phase III Trial Results Presented at ASCO
3. Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing
4. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
5. Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index
6. Delcath Enters Agreement to Sell 869,565 Units
7. Delcath Systems Granted Third Orphan Drug Designation
8. Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
9. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
10. Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
11. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... England and SAN JOSE, California ... Oxford BioTherapeutics, an international biotechnology company developing antibody-drug conjugates ... Reynolds MD, PhD to its Board of Directors. Dr ... the biotechnology industry, most recently as Chief Medical Officer ... welcome Tom at this transformative time for Oxford BioTherapeutics, ...
(Date:1/15/2014)... Two champions of science, technology, ... sponsorship of an annual competition for middle and ... and access to, innovative STEM study. The competition ... , TEAMS: Tests of Engineering Aptitude, Mathematics, ... the Technology Student Association (TSA). TEAMS provides hands-on ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of ... treatment of tinnitus. Patients listen to sound therapy ... over a period of weeks to months, their tinnitus ... Therapy in two forms: Notched Music and Notched White ... of a new form of Tailor-Made Notched Sound Therapy: ...
(Date:1/14/2014)... WASHINGTON , Jan. 14, 2014  3D Communications, a ... preparing for major scientific, regulatory, business, and media events in ... Europe , today announced its former associate Virginia ... Washington, D.C. office. Virginia Cox ... as Associate Commissioner for the Office of External Affairs at ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Former FDA Associate Commissioner Returns To 3D Communications 2
... FUQING CITY, China, July 7 /PRNewswire-Asia-FirstCall/ ... ("China Clean Energy", the "Company"),a producer of biodiesel ... resources in The People,s Republic of China,("PRC"), today ... second,quarter 2009, compared to the first quarter, driven ...
... /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin ... systems, today announced that data on the company,s SmartChip ... Annual Rediscovering Biomarkers Conference. The data will be ... and technical operations, as part of an oral presentation ...
... PARIS, France, July 7 Essilor is pursuing its,external ... America and the Middle East. , ... major,player in the Belgian market where the company is BBGR,s ... 92 employees, generated EUR17 million in 2008 revenue. The current,management ...
Cached Biology Technology:China Clean Energy Provides Business Update 2China Clean Energy Provides Business Update 3Data on WaferGen's SmartChip(TM) System to be Presented at 3rd Annual Rediscovering Biomarkers Conference 2Data on WaferGen's SmartChip(TM) System to be Presented at 3rd Annual Rediscovering Biomarkers Conference 3Data on WaferGen's SmartChip(TM) System to be Presented at 3rd Annual Rediscovering Biomarkers Conference 4Essilor: Essilor Forges New Strategic Partnerships Around the World 2
(Date:4/15/2014)... provides fixed carbon and energy for nearly all life ... remain mysterious. For example, little is known about how ... intensity. More fundamentally, we do not know the full ... perform photosynthesis in any organism. , , A type ... is a leading subject for photosynthesis research. Despite its ...
(Date:4/15/2014)... pairs, researchers from the Bloomberg School of Public ... reuptake inhibitors (SSRIs), a frequently prescribed treatment for ... autism spectrum disorder (ASD) and developmental delays (DD) ... edition of Pediatrics , analyzed data from ... population-based controls, where a uniform protocol was implemented ...
(Date:4/15/2014)... a line as it chased its next meal, the ... method to that mess, says Jane Wang, a Cornell ... to find simple physical explanations for complex, hardwired animal ... out the tiger beetle, known for its speed and ... its prey at blinding speeds. Publishing online April 9 ...
Breaking Biology News(10 mins):Study: SSRI use during pregnancy associated with autism and developmental delays in boys 2Photo: Tiger beetle's chase highlights mechanical law 2
... -- The University of Miami (UM) Rosenstiel School of ... with Seattle-based Troutlodge Marine to cooperate on the research ... species. The agreement calls for the joint training ... of knowledge and resources. Aquaculture is the fastest ...
... 9, 2009)The so-called "male lumpectomy"a minimally invasive interventional ... surgery in destroying diseased tumors and can be ... risk levels and particularly those who have failed ... of Interventional Radiology,s 34th Annual Scientific Meeting. Additionally, ...
... Calif. (March 9, 2009)A minimally invasive interventional radiology ... the pain of herniated diskswill become standard in ... predict researchers at the Society of Interventional Radiology,s ... the interventional radiologists examined just how ozone relieves ...
Cached Biology News:Troutlodge, University of Miami sign aquaculture agreement 2Freezing prostate cancer does a man's body good 2Freezing prostate cancer does a man's body good 3Freezing prostate cancer does a man's body good 4Freezing prostate cancer does a man's body good 5Oh, my aching back: Give me a shot of ozone 2Oh, my aching back: Give me a shot of ozone 3
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
... Console Orbital Shakers combine high durability ... programming power. The patented triple-counterbalanced ... unit to run with heavy out-of-balance ... system reduces contamination. The heavy ...
... Polynucleotide Kinase (PNK) catalyzes the transfer ... the 5'-hydroxyl of single- and double-stranded ... enzyme also removes the 3'-phosphate from ... 3', 5'-diphosphates to form a 3'-hydroxyl ...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Biology Products: